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Abstract
Kawasaki disease (KD) is a rare and often undiagnosed disease, at least in the 
western countries. Although its etiology remains unidentified, epidemiological 
features point to the role of infection and genetic predisposition. KD is character-
ized by an inflammatory acute febrile vasculitis. Coronary artery involvement is the 
most important complication of KD and may cause significant coronary stenosis 
resulting in ischemic heart disease. It has been demonstrated that the major risks in 
KD progression are the endothelial dysfunction and that systemic oxidative stress 
together with premature aging of red blood cells and alteration of platelet homeo-
stasis, could play a critical role in the cardiovascular complications associated with 
KD. This chapter will focus on the role of oxidative stress in endothelial damage and 
on circulating blood cells of KD patients.
Keywords: etiology, oxidative stress, inflammation, biomarkers,  
red blood cells, platelets
1. Introduction
Kawasaki disease (KD) is an inflammatory acute febrile vasculitis that can also 
lead to coronary artery weakening, aneurysm formation, and myocardial infarc-
tion. The incidence of this disease varies considerably between ethnic groups: 
in Asians are up to 20 times higher than Caucasians. KD is most prominently 
recognized in Japan, Korea, and Taiwan, reflecting increased genetic susceptibility 
among Asian populations. The highest incidence is reported in Japan: about 90 per 
100,000 [1, 2]. Although nearly 50 years have passed from the first description, the 
etiology of KD remains a mystery. Since the incidence of the disease is high among 
Japanese people, it can be speculated that this people may have some sort of genetic 
characteristic that leaves them susceptible to KD. In addition, both clinical and 
epidemiological findings strongly suggest that some infectious agent or bacterial 
super-antigenic toxin can play a pathogenetic role in genetically susceptible indi-
viduals [3]. Despite KD patients in the acute phase receive high-dose intravenous 
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immunoglobulin (IVIG) and aspirin therapy, up to 5% of those affected will 
develop coronary aneurysms, predisposing them to thrombotic complications that 
could result in atherosclerosis, myocardial infarction, and/or death [4]. In fact, risk 
factors for the development of atherosclerosis such as C-reactive protein (CRP), 
oxidative stress (OS), and inflammatory cytokines, are increased in the acute phase 
of KD [5]. Moreover, in the acute phase of the disease, often patients undergo 
thrombocytosis that can exert a pathogenic role in the cardiovascular complications 
that characterize KD. However, in KD progression, the major risk is endothelial 
injury and coronary artery weakening, favoring the formation of aneurysms in 1:5 
untreated children with KD as well as myocardial infarction, ischemic heart, and 
sudden death [6]. OS linked to inflammation that characterizes KD disease, has 
recently been included among the potentially useful diagnostic biomarkers in the 
vasculature of KD [7]. Several lines of evidence suggest that in KD patients, sys-
temic OS may promote: (i) endothelial dysfunction through increased production 
of oxygen- and nitrogen-derived species (ROS/RNS); (ii) alter red blood cell (RBC) 
homeostasis, resulting in a sort of premature aging in these circulating cells that 
could lead to anemia and formation of blood clots; and (iii) stimulate platelet func-
tions and defective platelet apoptosis program, resulting in thrombocytosis that can 
exert a pathogenetic role in the cardiovascular complications occurring in KD [8].
2. Kawasaki disease etiology
The etiology of KD remains one of the major mysteries in the field of Pediatrics, 
and no specific biological markers for diagnostic testing have been characterized 
to date. A large body of clinical, epidemiologic, immunologic, pathologic, and 
ultrastructural evidence suggests that environmental factors or infectious agents 
induce an intense inflammatory host response in genetically susceptible individuals 
[3]. The clinical findings of conjunctival injection, oral and pharyngeal erythema, 
cervical adenopathy, and rash, observed in patients with KD, are very similar to 
those observed in other pediatric infections acquired by the respiratory route.
2.1 Infections
Even if not confirmed, many published reports implicate a number of bacte-
rial or viral pathogens such as Staphylococcus, Streptococcus, Adenovirus, human 
herpes virus 6 (HHV-6), Epstein Barr virus (HBV), human T-lymphotropic virus 
(HTLV), coronavirus and human bocavirus (HBoV) [9–19]. Staphylococci and 
Streptococci release exotoxins, known as super-antigens that promote the activa-
tion of a large numbers of T helper (Th) cells (5–20% of T cell clones) leading to 
an extensive immunological reaction [20]. Matsubara and collaborators state that 
toxic shock syndrome toxin-1 (TSST-1), Streptococcal Pyogenic Exotoxin A or C 
(SPEA or SPEC), and Staphylococcal Enterotoxin A or B (SEA or SEB) may act 
as super-antigens that could stimulate the immune system and result in KD [21]. 
However, despite an increase in: (i) anti-streptococcal SPEC antibodies in the sera 
of KD patients in acute phase [22] and (ii) anti-SPEC and -SPEA IgM found in the 
first few weeks following the illness [21], no significant differences in super-antigen 
antibody were found from some serological studies.
2.2 Immune dysregulation
Most investigators believe that derangement of the immune system and func-
tional disorder of Th cells are the primary pathophysiologic features in patients with 
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KD [23]. Data analyses for KD show that abnormal immune responses to infectious 
agents play key roles in disease initiation. It has been reported that, in the acute 
phase of KD, viral or bacterial super-antigens act by binding to the Vβ region of 
the T cell receptor inducing a widespread immunological response and resulting 
in the release of pro-inflammatory cytokines such as tumor necrosis factor (TNF) 
α, interleukin (IL) 1β, 6, 8, interferon (IFN) γ, and chemokines, such as monocyte 
chemotactic protein-1 (MCP-1) [3, 24]. In fact, it has been found that serum levels 
of some cytokines, such as IL-6, IL-20, TNF-α, and IFN-γ increase significantly 
before IVIG treatment and that levels of IL-6, IL-10, and IFN-γ decreased rapidly 
after treatment [25]. Moreover, studies in a murine systemic vasculitis, induced 
by Candida albicans extract, emphasize a relationship between the development 
of vasculitis and the overexpression of pro-inflammatory cytokines, such as 
TNF-α and IL-6 [26, 27]. The activation of the immune system and the cascade of 
inflammatory factors are considered as important features of KD. In fact, Th cells, 
mononuclear cells, macrophages and plasma cells, with a smaller number of neu-
trophils, are observed in various organ tissues of fatal cases of acute KD [23]. When 
activated, T helper cells mainly differentiate into two functionally distinct subsets, 
Th1 and Th2 cells. Th1 cells play an important role in cellular immunity by secreting 
IL-2 and IFN-γ, while Th2 cells involve the development of antibody-producing B 
cells via the secretion of IL-4, IL-5, IL-6, and IL-10. Some of these cytokines play an 
important role in the progression from systemic activation of the immune system 
to local inflammation in coronary vessels. Recently, it has been demonstrated 
that KD patients may be non-responsive to IVIG when, after IVIG treatment, the 
serum levels of IL-6 and IL-10 decrease slowly and the levels of IL-4 and TNF-α 
increase [25]. Although activation of the immune system and production of various 
cytokines have both been reported in patients with KD, the role of T cells and the 
functional state of Th1 and Th2 cells in KD are still not fully understood. Moreover, 
an imbalance between the line Th 17 (Th17) and regulatory T (Treg) cells has been 
described in the peripheral blood from patients with KD [28]. Th17 cells have been 
identified as inflammation regulators via production of distinct cytokines, such as 
interleukin IL-17. Conversely, to the Treg cells expressing FOXP3 has been attrib-
uted an anti-inflammatory role via production of anti-inflammatory cytokines, for 
example, IL-10 and TGF-β1 [29]. T helper cells involved in KD etiology are listed in 
Figure 1 and Table 1.
2.3 Genetics
For decades, researchers attempted to identify candidate genes conferring sus-
ceptibility to the KD. In particular, studies on genes related to innate and acquired 
immune functions or to vascular remodeling, have been conducted [30]. Genes 
for analyses were selected based on the information of their known function or 
role in the disease pathophysiology. Initial genetic studies were focused on human 
leukocyte antigen (HLA) genes, located at chromosome 6p21.3, that encode the 
protein on the cell-surface antigen-presenting proteins, involved in the regulation 
of the immune system. The roles of HLA genes have been investigated in several 
immune-mediated vascular diseases, including KD. The results of such studies 
vary depending on the ethnic group studied. A recent genome-wide association 
study demonstrated the significant association of HLA class II region (HLA-
DQB2-DOB) with KD in a Japanese population [31]. A genome-wide association 
study conducted in a Korean population demonstrated a significant association 
with KD of the HLA class I locus that contains the HLA-B and HLA-C genes [32]. 
These studies suggest that either HLA class I or class II may be associated with 
KD and play a role in KD pathogenesis. Several reports show associations between 
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KD and specific HLA genotypes including HLA-B54 in a Japanese population 
[33], HLA-B51 in Caucasian populations [34], HLA-B35, -B75, and -Cw09 in 
Korean [35], and the major histocompatibility complex class I chain-related gene 
A (MICA) genes in southern Chinese [36]. Genome-wide association studies 
(GWASs) have identified several susceptibility genes associated with KD, includ-
ing CD40L, HLA-E, BLK, and FCGR2A [37–40]. CD40L gene, located on Xq26, is 
known to induce endothelial cells to produce cell adhesion molecules and chemo-
kines. Its expression has been found elevated on CD4+ Th cells and platelets dur-
ing the acute-phase KD and in KD patients with coronary artery lesions (CALs) 
Figure 1. 
T helper cells involved in KD etiology. In the acute phase of Kawasaki disease, viral or bacterial super-antigens 
induce immunological response resulting in the release of cytokines. Th cells are regulators of inflammation. T 
helper 1 cells secrete interferon g (IFN-g) and interleukin 2 (IL-2); T helper 2 cells secrete interleukin 4, 5, 6, 
and 10; T helper 17 cells secrete interleukin 17 (IL-17). Conversely, regulatory T cells (Treg) have an anti-
inflammatory role via production of interleukin 10 (IL-10) and growth factor-beta (TGF-b).
T helper cells Functions
Th1 Regulate cellular immunity by secreting IL-2 and IFN-γ
Th2 Regulate humoral immunity by secreting IL-4, IL-5, IL-6, and IL-10
Th17 Regulate inflammation by secreting IL-17
Treg Anti-inflammatory role by the release of IL-10 and TGF-β1
Treg, regulatory T cells.
Table 1. 
Immune dysregulation in KD: role of T helper cells.
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[41]. HLA-E is a known ligand of CD94/natural killer cell receptor group 2-A 
(NKG2-A) and CD94/NKG2-C, which are expressed on natural killer cells [38]. 
Recent studies have shown that HLA-E has regulatory functions in both the innate 
and adaptive immune responses and that may have important implications in the 
pathogenesis of immune-mediated vascular diseases [42]. BLK is a Src family 
tyrosine kinase expressed primarily in the B-cell lineage and located on chromo-
some 8p22-23. During the acute and convalescent stages of KD, BLK expression 
correlates with the percentage of B cells in the peripheral blood mononuclear cells. 
Importantly, a decreased BLK expression in peripheral blood B cells may alter B 
cell function and predispose individuals to KD [43]. The BLK was significantly 
associated with KD susceptibility in Taiwanese and in Japanese populations [43]. 
FCGR2A gene is on chromosome 1q23 and encodes the FcγRIIA protein (CD32a), 
a member of a family of receptors for IgG (including the A, B, and C subunits of 
FcγRI and FcγRII and the A and B subunits of FcγRIII). This receptor is found on 
the surface of many immune cells, including natural killer cells, macrophages, 
and neutrophils, and it is involved in cellular activation and uptake of immune 
complexes [44]. The FCGR2A is associated with KD susceptibility in Korean and 
Asiatic populations [30]. Genes related to vasoactive or angiogenic molecules 
also can be considered as candidates for KD susceptibility or severity. Ohno and 
co-worker have shown that an up-regulation of vascular endothelial growth factor 
(VEGF) is involved in formation of coronary artery lesions (CALs) [45]. VEGF, 
expressed in various types of cells including leukocytes and vascular smooth 
muscle cells, binding to its receptor (VEGFR-1 and VEGFR-2) expressed on 
endothelial cells induces cell proliferation, survival, migration, and angiogenesis. 
Its ability to induce vascular hyper-permeability and chemotaxis of bone marrow-
derived cells suggest significant roles of VEGF in inflammation [45]. Other 
candidate genes for KD are transforming growth factor-beta (TGF-β), because 
TGF-β-mediated T-cell activation and cardiovascular remodeling are important 
features of KD. This gene, located on chromosome 19q13.1, modulates the balance 
of pro-inflammatory/anti-inflammatory T cells through a complex set of interac-
tions [46]. Genetic variations in the TGF-β pathway may lead to an imbalance of 
pro-inflammatory and regulatory T cells (Treg) by affecting the expression of 
the forkhead/winged helix transcription factor P3 (FOXP3) that is involved in the 
differentiation, function, and survival of CD4 + CD25+ regulatory T cells. Several 
studies demonstrated that in the peripheral circulation of KD patients, Treg cell 
numbers were reduced, and their function compromised [47]. Recently, in KD, 
191 genes mainly implicated in inflammation and innate immune response and 
some signaling pathway such as platelet activation have been identified. Among 
these genes, MAPK14 and PHLPP1 were considered as the key functional genes 
that can distinguish KD from common infectious illness [48]. MAPK14 is a gene 
that encodes p38α, a MAP kinases implicated in various cellular processes includ-
ing proliferation, differentiation, transcription regulation, and development 
[49]. MPK14/P38 was found to significantly improve endothelial function and 
inflammation after vascular injury. PHLPP1 encodes a protein that is a member of 
the Ser/Thr phosphatase family. Its upregulation in acute KD may reduce vascular 
injury by inactivating Akt and subsequent reducing the expression of NO [48]. 
Moreover, genetic polymorphisms of 1,4,5-trisphosphate 3-kinase C (ITPKC) 
and caspase 3 (CASP3) have been shown to associate with coronary artery lesions 
formation in both Japanese and Taiwanese populations of KD patients [50]. 
ITPKC is a gene located on chromosome 19q23 that acts as a negative regulator of 
T-cell activation. CASP3 is a gene located on chromosome 4q35, that is related to 
the apoptosis of immune cells [50]. Candidate genes in the KD etiology are listed 
in Table 2.
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2.4 Environmental factors
Environmental factors, including socio-economic status and cultural habits 
in a society, affect the occurrence of infectious and autoimmune diseases. Recent 
studies suggest that environmental triggers, such as air pollution and extreme 
temperatures, may also serve as risk factors for KD [51]. Particulate matter and vari-
ous gaseous pollutants, contained in the ambient air, have strong oxidizing property 
and the potential to induce KD through exaggerated inflammatory response, 
which is heavily involved in the pathophysiologic process of KD development [52]. 
Short-term exposure to air pollutants may damage endothelial cells, impair vascular 
function, stimulate systemic inflammation response, increase oxidative stress, and 
induce cardiac ischemia and repolarization abnormalities [52–54], consequently 
contributing to the development of KD. Moreover, from a time-stratified case-
crossover study in Taiwan, evidence has been provided that exposure to ozone (O3) 
may increase the risk of KD in children [55].
Recently, a study carried out on the Japanese population has found an associa-
tion between higher household income, urbanization, and smaller family size at 
birth with increased KD incidence, which raises the hygiene hypothesis for the 
etiology of KD [56].
It has been reported that the human immune system and microbiota are try-
ing to adapt to a changing environment. Gut microflora of infants were different 
Candidate genes Locus Populations Function
HLA-B54 6p21.3 Japanese Regulation of the immune system
HLA-B51 6p21.3 Caucasian Regulation of the immune system
HLA-B35 6p21.3 Corean Regulation of the immune system
HLA-B75 6p21.3 Corean Regulation of the immune system
HLA-E 6p21.3 Taiwanese CAL formation
HLA-Cw09 6p21.3 Corean Coronary complication
MICA 6p21.3 Southern Chinese CAL formation
CD40L Xq26 Taiwanese CAL formation
BLK 8p22-23 Taiwanese and 
Japanese
Correlation with the % of B cells during KD
FCGR2A 1q23 Korean and Asiatic Cellular activation and uptake of immune 
complexes
VEGF 6p12 Japanese CAL formation
TGF-β 19q13.1 European Modulates the balance of proinflammatory/
anti-inflammatory T cells
MAPK14 6p21.31 Chinese Autoimmunity-related vasculitis
PHLPP Chinese Reduce vascular injury
ITPKC 19q23 Taiwanese Inactive T cells
CASP3 4q35 Taiwanese Apoptosis in immune cells
HLA, human leukocyte antigen; MICA, major histocompatibility complex class I chain–related gene A; 
BLK, B-lymphoid tyrosine kinase; FCGR2A, Fc fragment of IgG receptor IIa; VEGF, vascular endothelial growth 
factor; TGF-β, transforming growth factor-beta; MAPK14, mitogen-activated protein kinase 14; PHLPP, PH domain 
leucine-rich repeat-containing protein phosphatase 1; ITPKC, 1,4,5-trisphosphate 3-kinase C; CASP3, caspase 3.
Table 2. 
Candidate genes conferring susceptibility to the KD.
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according to ethnic groups, and the changing environment factors from industri-
alization may affect the distribution of gut microflora in infants [57]. Thus, it is 
very possible that normal flora also adjusts to a changing environment. Presently, 
the majority of data has found that the composition of the gut microbiota in KD 
patients differs from healthy subjects. Lee and co-workers have hypothesized that 
the immune system should lose tolerance to a part of the resident intestinal flora 
and that environmental factors, that is, a Western lifestyle or improved public 
hygiene systems, could transform the commensal flora into a pathogen one, as 
observed in different gastrointestinal disorders [58].
3. Implication of systemic oxidative stress in KD
It has been recognized that a systemic pro-oxidant state associated with inflam-
mation can play a key role in the pathogenesis and progression of KD [59]. In 
support to this theory, experimental evidences showed increased concentration of 
oxidative stress-related biomarkers such as ROS/RNS, malondialdehyde (MDA), 
protein 3-nitrotyrosine, asymmetric dimethylarginine (ADMA), and myeloperoxi-
dase (MPO). ROS/RNS are chemical heterogeneous molecules that include radical 
species, such as superoxide anion (O2
•−), hydroxyl radicals (•OH), and nitric oxide 
(•NO) and non-radical species such as hydrogen peroxide (H2O2,) and peroxynitrite 
(the product of the fast reaction between O2
•− and •NO). Peroxynitrite-mediated 
oxidation includes its direct reaction with several cellular targets (CO2, hemopro-
teins, and thiols), as well as indirect reaction, CO2-dependent oxidations mediated 
by strong oxidizing radicals, such as •NO2 and carbonate radical (CO3
•). The pro-
duction of these oxidants is known to generate in blood a pro-oxidant status able to 
promote the occurrence of oxidative- and nitrative stress as well as redox imbalance 
leading to altered cell signaling and functions. These events may play a pathogenetic 
role in the cardiovascular complications often associated with KD [8]. As already 
mentioned, ROS/RNS generically can react with all the macromolecules of biologi-
cal importance in cell and tissues, generating oxidative modification in lipids, DNA, 
and proteins that, in some cases, can be the footprint of the oxidant generated [60]. 
Malondialdehyde (MDA), the most investigated end-products of lipid peroxidation, 
is one of several low-molecular-weight end-products formed via the decomposition 
of certain primary and secondary lipid peroxidation products. It is a specific marker 
of omega-3 and omega-6 fatty acids peroxidation [61]. Increased serum levels of 
MDA were found in KD patients with coronary aneurysm associated with carotid 
intima-media thickening and stiffening [59]. Another marker of lipid peroxidation 
evaluated in KD patients is 8-isoprostaglandin F2α (8-iso-PG), a non-enzymatic 
oxidation product of arachidonic acid. Increased levels of 8-iso-PG have been 
measured in the urine from acute KD patients before IVIG therapy [62, 63]. Its 
increase reflects an enhanced endothelial dysfunction and correlates with cardiac 
dysfunction in acute KD [62]. Protein tyrosine nitration is an oxidative post-trans-
lational covalent modification of tyrosine residues consisting, in the addition of a 
nitro group (▬NO2) to the position 3, of the phenolic ring leading to the formation 
of 3-nitrotyrosine as an end-product [64]. It is a free-radical-mediated reaction 
induced by the one-electron oxidation of tyrosine residues to tyrosyl radical 
followed by its fast reaction with the nitrating agent •NO2. In biological systems, 
3-nitrotyrosine formation is mediated mainly by peroxynitrite-derived strong 
oxidants, such as •OH, •NO2, CO3
• [64]. In addition, 3-nitrotyrosine formation can 
be mediated by metals of heme-containing peroxidases in the presence of H2O2 and 
nitrite. The H2O2-genereted oxo-metal compounds (O = MnIV) and compounds I 
and II of heme-containing peroxidases, such as MPO, are highly heme oxidation 
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state complexes able to oxidize tyrosine to tyrosyl radical, which in the presence of 
•NO2, generate 3-nitrotyrosine [65, 66]. Protein tyrosine nitration is considered a 
hallmark of the reactions involving •NO-derived oxidant, that is, peroxynitrite and 
•NO2, able to dramatically affect protein structure and function. Indeed, the 
occurrence of this oxidative modification leads to a loss- (superoxide dismutase, 
prostacyclin synthase, etc.) or to a gain-of-function (cytochrome c, protein kinase, 
glutathione S-transferase, etc.) of key macromolecules able to affect cell homeosta-
sis and fate [64]. The well-established association of protein tyrosine nitration to 
several pathologies, such as cardiovascular disease, neurodegeneration, inflamma-
tion and cancer has made this protein modification not only a biomarker of RNS-
derived oxidative stress in vivo, but also a predictor of disease onset and 
progression. MPO is a pro-oxidant enzyme released by activated poly-morphonu-
clear leukocytes that can promote the pro-inflammatory state by inducing the 
formation of RNS, 3-nitrotyrosine, and lipid peroxidation [65]. Furthermore, it can 
promote a blood pro-coagulant state favoring the binding of oxidized lipoproteins 
to the specific receptor present on the surface of platelets [67]. In this regard, 
3-nitrotyrosine and MPO could play a pathogenetic role in the cardiovascular 
complications of KD and could be considered as biomarkers of inflammation in this 
disease. Indeed, elevated MPO levels were detected in acute KD patients before 
IVIG treatment [8]. It has been recognized that a persistent OS and an excessive 
ROS production play an integral role in the endothelial and smooth muscle dysfunc-
tion leading to the risk of premature arteriosclerosis in KD patients [68]. A longer 
duration of fever is associated with higher risk of oxidative stress-induced endothe-
lial dysfunction [68]. ADMA, produced following the catabolism of proteins 
containing methylated arginine residues, is an endogenous inhibitor of the enzyme 
nitric oxide synthase (NOS), regulating the nitric oxide bioavailability. Many 
disease states, including cardiovascular diseases and diabetes, are associated with 
increased plasma levels of ADMA [69]. This compound could therefore play a 
crucial role in the pathogenesis of diseases associated with endothelial dysfunction, 
so that it has been proposed as a biomarker for cardiovascular risk. In plasma from 
KD patients, low levels of ADMA were detected before IVIG treatment and associ-
ated with coronary abnormalities [8, 70]. Moreover, it has been suggested that a 
pro-oxidant blood status could alter RBC homeostasis [71]. RBCs, under physiologi-
cal conditions, represent the major components of blood antioxidant capacity and 
the cells with higher resistance to oxidative stress [71]. They exert a scavenging 
activity with a particular regard for ROS and for the species derived from nitric 
oxide, often overproduced in inflamed tissues. In fact, crossing inflamed areas can 
contribute to detoxify ROS and RNS “protecting” cells (e.g. endothelial cells). In 
contrast, when they cross a tissue where an intense production of ROS occurs, they 
may accumulate oxidative damage and become a source of reactive species capable 
of modifying the behavior and fate of endothelial cells [72]. In KD patients, altera-
tions of RBCs, typically associated with oxidative imbalance, have been detected 
[8]. In particular, increased ROS levels and reduced intracellular total thiol content 
were measured in RBCs from KD patients before treatment with IVIG and aspirin. 
In addition, the appearance of RBCs with alterations typically associated with 
premature aging (e.g. glycophorin A and CD47 expression) or eryptosis (e.g. 
clustering of band 3 and increase of phosphatidylserine externalization) was 
observed. Glycophorin A (GA) is a glycoprotein widely expressed at the RBC 
surface that is downregulated during senescence. CD47 is an integrin-associated 
protein. Known as thrombospondin receptor, it acts as marker of self. Band 3 is an 
ion exchanger involved in RBC adhesion to endothelium. Phosphatidylserine (PS) is 
a phospholipid normally localized to the inner leaflet of the plasma membrane. 
During cell remodeling, it is externalized to the outer leaflet leading to RBC aging 
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and death (eryptosis). Importantly, the appearance of aged and eryptotic RBCs in 
KD patients correlates with some clinical evaluations. In fact, it has been found that 
during the first 5 days of hospitalization, the number of RBCs, hemoglobin, mean 
corpuscular value, and hematocrit decrease significantly [8]. In addition, prema-
ture aging of RBCs, and their consequent removal from circulation, might be a risk 
factor for anemia: condition that can be found in KD patients. Furthermore, it has 
Figure 2. 
Oxidative stress and vascular implications in Kawasaki disease. The Kawasaki disease (KD) is characterized 
by acute inflammation that has tissue oxidative stress as hallmark. This condition boosts the increase of reactive 
oxygen (ROS) and nitrogen (RNS) species formation in tissues and in the vasculature through the activation 
of the related producing enzymes in the cytosol. The cytosolic enzymes include the different isoforms of NADPH 
oxidase (NOXs), nitric oxide synthase (NOS), cyclooxygenase (COX), xanthine oxidase (OX), asymmetric 
dimethylarginine (ADMA), uncoupled endothelial NOS (eNOS), and myeloperoxidase (MPO). Other 
potential sources of ROS and RNS are the oxidized RBCs (oxRBCs) and lipid peroxidation. The Kawasaki 
disease is also characterized by the down-regulation of the antioxidant systems, including the depletion of 
GSH concentration and the decrease in the activity of the detoxifying enzymes, such as superoxide dismutase 
(SOD), catalase (Cat) glutathione peroxidase (Gpx), glutathione reductase (GR) and the couple constituted by 
thioredoxin (Trx) and thioredoxin reductase (TrxR). These conditions result in the irreversible accumulation 
of oxidation products in proteins, lipids, and sugars, which allow to the impairment of the intracellular 
redox signaling and detrimentally affect vascular biology by promoting vascular inflammation, endothelial 
dysfunction, and vascular remodeling. These alterations underlie the typical KD-associated cardiovascular 
complications, such as coronary artery weakening, aneurysm formation, and myocardial infarction.
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been hypothesized that in KD patients, oxidative stress can alter platelet functions 
and platelet apoptosis program resulting in thrombocytosis that can exert a patho-
genetic role in the cardiovascular complications [47]. This hypothesis is supported 
by the detection of markers of platelet activation, such as P-selectin shedding and 
PS externalization. P-selectin is a cell-adhesion molecule constitutively expressed in 
the α-granules of resting platelet. It translocates at the surface during platelet 
activation and subsequently released by a shedding phenomenon. Its release 
modulates leucocyte adhesion to both platelets and endothelial cells during inflam-
matory responses and thrombus formation [73]. PS externalization in platelets is 
usually associated with a sort of programmed cell death and correlated with their 
hyper-activation. In KD patients, before treatment with IVIG and aspirin, two 
different sub-populations of platelets have been identified: (i) annexin V positive 
platelets, characterized by a decreased mitochondrial membrane potential and 
Plasmatic biomarkers Specificity Clinical findings 
in KD
ROS/RNS (O2
•−, •OH, •NO, 
H2O2)
Generates in blood a pro-oxidant status Increased levels
MDA Specific marker of omega-3 and omega-6 
fatty acids peroxidation
Increased levels
Protein 3-nitrotyrosine End-product of modification of tyrosine 
residues
Increased levels
ADMA Endogenous inhibitor of the endothelial 
NOS. Regulates the NO bioavailability
Decreased levels
MPO Pro-oxidant enzyme that can promote the 
pro-inflammatory state
Increased levels
RBC biomarkers
Glycophorin A Glycoprotein downregulated during RBC 
senescence
Down-regulated
CD47 Thrombospondin receptor that acts as a 
marker of self
Down-regulated
Band 3 Ion exchanger involved in RBC adhesion to 
endothelium
Down-regulated
PS externalization Phospholipid, marker of RBC aging and 
death when externalized to the outer leaflet 
of the plasma membrane
Increased percentage 
of RBCs with 
externalized PS
Platelet biomarkers
P-selectin A cell-adhesion molecule that modulates 
leucocyte adhesion to both platelets and 
endothelial cells during inflammatory 
responses and thrombus formation
Shedding
PS externalization and loss 
of mitochondrial membrane 
potential
Biomarkers of pro-coagulant platelets Detected
Mitochondrial membrane 
hyperpolarization without PS 
externalization
Biomarkers of potentially pro-coagulant 
platelets
Detected
ROS/RNS, oxygen- and nitrogen-derived species; O2
•, superoxide anion; •OH, hydroxyl radicals; •NO, nitric oxide; 
H2O2, hydrogen peroxide; MDA, malondialdehyde; ADMA, asymmetric dimethylarginine; MPO, myeloperoxidase; 
RBC, red blood cell; PS, phosphatidylserine; NOS, nitric oxide synthase.
Table 3. 
Biomarkers of oxidative stress in KD.
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defined as activated pro-coagulant platelets [74] and (ii) annexin V negative 
platelets, characterized by an increased mitochondrial membrane potential, prone 
to become pro-coagulant when in contact with adenosine diphosphate (ADP) and 
thromboxane, mediators normally released from activated platelets [75]. It has been 
hypothesized that in KD patients, activated pro-coagulant platelets could contrib-
ute to the increased thrombotic risk detected in these patients. Implication of 
oxidative stress in KD is depicted in Figure 2. Biomarkers of oxidative stress in KD 
patients are summarized in Table 3.
4. Conclusions
In this chapter, a complex framework of events contributing to the etiology 
of KD has been described. These include some type of bacterial or viral infec-
tion, genetic determinants, immune system as well as hematological alterations. 
Although epidemiological and clinical data suggest that KD may arise from an 
abnormal response to infectious diseases in genetically susceptible individuals, 
there are still many controversies about the etiology of KD. There is no agree-
ment on KD-related infectious agents, and the immune mechanisms behind KD 
remaining only partially known. Only the basic research evaluating the pathogenic 
mechanisms of this disease will probably find new targets for identifying disease-
modifying agents or therapies that are more specific. Moreover, in this chapter, we 
provided new lines of evidence supporting the hypothesis that systemic oxidative 
stress together with premature aging of RBCs and platelets could play a critical role 
in the cardiovascular risk observed in patients with KD.
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